Catherine Huntington

Title: Catherine Huntington: Innovator in Therapeutic Binding Molecules

Introduction

Catherine Huntington is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of therapeutic binding molecules, holding a total of 3 patents. Her work focuses on innovative solutions for treating various diseases, particularly those related to chemokine receptors.

Latest Patents

Catherine's latest patents include groundbreaking inventions such as therapeutic binding molecules that target the chemokine receptor CCR9. This invention is particularly relevant for the treatment of CCR9-mediated diseases, including inflammatory bowel disease (IBD). Another notable patent involves anti-Siglec-15 antibodies, which are utilized in the treatment of leukemia, specifically acute myeloid leukemia. These advancements highlight her commitment to addressing critical health challenges through innovative research.

Career Highlights

Throughout her career, Catherine has worked with esteemed organizations such as Medimmune Limited and Cambridge Enterprise Limited. Her experience in these companies has allowed her to develop and refine her inventions, contributing to the advancement of medical science.

Collaborations

Catherine has collaborated with notable individuals in her field, including John Gawain Elvin and John Trowsdale. These partnerships have further enriched her research and development efforts.

Conclusion

Catherine Huntington stands out as a dedicated inventor whose work in therapeutic binding molecules has the potential to transform treatment options for various diseases. Her innovative spirit and collaborative efforts continue to drive advancements in medical research.